Developmental Funds

发展基金

• 批准号: 7991463
• 负责人: Harvey R. Herschman
• 金额: $ 19.02万
• 依托单位: UNIVERSITY OF CALIFORNIA LOS ANGELES
• 依托单位国家: 美国
• 财政年份: 2010
• 资助国家: 美国
• 起止时间: 2010-07-01 至 2015-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7991463
• 关键词: Animal Model; Comprehensive Cancer Center; Development; Diagnosis; Funding; Goals; Image; Malignant Neoplasms; Molecular; Monitor; Progress Reports; Publications; Research; Research Personnel; Resources; Rome; Technology; anticancer research; cancer imaging; in vivo Cellular and Molecular Imaging Centers; medical schools; molecular imaging; pre-clinical

Since this submission is a competitive renewal, we will first present a brief Background to describe how our Developmental Funds have been/will be used. We support four Developmental Fund Projects annually, at $45-50K per project. Projects are for up to two years; second year funding competes in the pool with first year funding applicafions. Our initial goal for our Developmental Funds was to facilitate introduction of molecular imaging to UCLA cancer research; to bring the strongest molecular, cellular and cancer researchers into the imaging arena and to proselytize for use of non-invasive imaging in fundamental cancer research. In our current funding cycle, three of the four Research component Projects were new, and grew out of Developmental Funds Projects. Funding our competing ICMIC renewal is perhaps the best objective testimony that we achieved our goal. The narratives below describe proposed Developmental Fund Projects for year 1 of the renewal application. During this current cycle, the Jonsson Comprehensive Cancer Center and the Dean for Research for the David Geffen School of Medicine have also contributed funds to support related projects, in consultafion with Dr. Herschman (for details see Secfion A, Description).

由于此提交是竞争性的续约，因此我们将首先介绍 背景描述我们的发展基金的使用方式。我们支持四个 每年的开发基金项目每年$ 45-50K。项目最多两年；第二年资金与第一年的资金应用程序在游泳池竞争。我们的最初目标 发展基金是为了促进向UCLA癌症研究引入分子成像。将最强大的分子，细胞和癌症研究人员带入成像领域，并在基本癌症研究中进行非侵入性成像的倾向。在我们目前的筹资周期中，四个研究组成项目中的三个是新的，并从开发基金项目中发展出来。资助我们竞争的ICMIC更新也许是我们实现目标的最佳客观证词。下面的叙述描述了续签应用第一年的拟议发展基金项目。 在当前周期中，Jonsson综合癌症中心和David Geffen医学院的研究院长还为与Herschman博士进行了协商（有关详细信息，请参见Secfion A，描述），为支持相关项目提供资金。